US equities
|
MU
$904.90
▲+0.00%
SNDK
$1,371.12
▲+0.00%
NVDA
$217.09
▲+0.00%
SPCX
$147.96
▲+0.00%
SKHY
$142.87
▲+0.00%
AAPL
$342.94
▲+0.00%
TSLA
$368.06
▲+0.00%
CRWV
$61.12
▲+0.00%
MU
$904.90
▲+0.00%
SNDK
$1,371.12
▲+0.00%
NVDA
$217.09
▲+0.00%
SPCX
$147.96
▲+0.00%
SKHY
$142.87
▲+0.00%
AAPL
$342.94
▲+0.00%
TSLA
$368.06
▲+0.00%
CRWV
$61.12
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Articles published by Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 18, 2026
From
Fennec Pharmaceuticals Inc.
Via
GlobeNewswire
Tickers
FENC
TSX:FRX
Fennec Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update
May 14, 2026
From
Fennec Pharmaceuticals Inc.
Via
GlobeNewswire
Tickers
FENC
TSX:FRX
Fennec Pharmaceuticals to Report First Quarter 2026 Financial Results on May 14, 2026
May 07, 2026
From
Fennec Pharmaceuticals Inc.
Via
GlobeNewswire
Tickers
FENC
TSX:FRX
Fennec Pharmaceuticals Announces Acceptance of Abstracts at the 2026 ASCO Annual Meeting
April 21, 2026
From
Fennec Pharmaceuticals Inc.
Via
GlobeNewswire
Tickers
FENC
TSX:FRX